Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Panchenko Ep"'
Autor:
A N Rogoza, Marina V. Kostiukevich, Panchenko Ep, Iuliia A. Iuricheva, Alexander Litvin, E. Zheleznova, I E Chazova, E M Elfimova, Madina D. Utsumueva, Sergei P. Golitsyn, Lada Iu. Laiovich, Juliya V. Zhernakova, Kropacheva Es, Nikolai Iu. Mironov
Publikováno v:
Системные гипертензии, Vol 18, Iss 3, Pp 105-128 (2021)
Arterial hypertension (AH) is a leading risk factor for cardiovascular disease as well as it is the most common, independent and potentially reversible risk factor for atrial fibrillation (AF). AH contributes to the occurrence and maintenance of AF d
Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
Autor:
Olga Barbarash, A. A. Shiryaev, M. M. Ruda, A. N. Samko, Kukharchuk Vv, G. L. Soboleva, V. M. Mironov, Panchenko Ep, Yu. A. Karpov, A. A. Boschenko, V. V. Kashtalap
Publikováno v:
Eurasian heart journal. :54-93
Disclaimer The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event
Autor:
Komarov Al, AG Shuleshova, Elena Yarovaya, Panchenko Ep, O O Shakhmatova, MV Andreevskaya, V V Korobkova
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 30-38 (2020)
Upper gastrointestinal (UGI) bleeding is a common complication of antiplatelet therapy. Data from real clinical practice that characterize the range of risk factors for UGI bleeding, prophylactic proton pump inhibitors (PPIs) therapy, bleeding freque
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 15-23 (2020)
To analyze the frequency of resumption of anticoagulant therapy (ACT) after major and clinically significant bleeding among AF patients who received oral anticoagulants and were observed in the Department of clinical problems of atherothrombosis from
Autor:
N P Mitkovskaya, A O Konradi, Komarov Al, E I Tarlovskaya, Ye V Shlyakhto, V A Snezhitskiy, S V Malchikova, A I Chesnikova, L V Kolotsey, M M Petrova, A B Sugraliyev, V V Skibitsky, A G Arutyunov, N. A. Koziolova, Ya A Orlova, Tereshchenko Sn, Kropacheva Es, G P Arutyunov, I. V. Fomin, Yu N Belenkov, Panchenko Ep, I. S. Yavelov, Ardashev Av, I I Shaposhnik, N Yu Grigorieva, G A Dzhunusbekova, S G Kanorskii, A P Rebrov, Hamayak Sisakian, E G Zhelyakov, O. M. Drapkina
Publikováno v:
Kardiologiia. 60:4-14
This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific fea
Autor:
Yu. A. Fedotkina, Panchenko Ep
Publikováno v:
Атеротромбоз, Vol 0, Iss 2, Pp 46-54 (2020)
Oncological disease is one of the most important risk factors for venous thromboembolic complications (VTEC). The treatment of an already confirmed VTEC in an oncological patient is always associated with additional difficulties, which are related to
Publikováno v:
Терапевтический архив, Vol 91, Iss 9, Pp 38-46 (2019)
To evaluate efficacy and safety of reduced dose of direct oral anticoagulants (DOACs) as part of triple antithrombotic therapy in AF patients, undergoing elective percutaneous coronary intervention (PCI), and to identify factors, associated with this
Autor:
A. V. Protopopov, S. R. Gilyarevskyi, Olga Barbarash, R. M. Shakhnovich, V. A. Markov, B. G. Alekyan, E. D. Kosmacheva, Tereshchenko Sn, N. N. Nikulina, S. A. Ustyugov, E. Yu. Vasilieva, S. A. Abugov, N. A. Gratsiansky, A. V. Khripun, V. A. Shpektor, Yu. M. Lopatin, S. V. Shalaev, A. S. Galyavich, Vladimir I. Ganyukov, Dmitry V. Duplyakov, Yu. A. Karpov, Dmitry Skrypnik, N. V. Pogosova, M. V. Arkhipov, A. N. Yakovlev, E. P. Golubev, Panchenko Ep, D. V. Pevzner, E. Z. Golukhova, D. A. Zateischikov, S. S. Yakushin, I. S. Yavelov
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 4 (2021)
Endorsed by: Research and Practical Council of the Ministry of Health of the Russian Federation.
Autor:
I. S. Yavelov, Yu N Belenkov, Olga Barbarash, Dmitry V. Duplyakov, S R Gilarevsky, Svetlana Villevalde, I. B. Bondareva, Yu V Mareev, S. Yu. Martsevich, A. S. Galyavich, N. A. Koziolova, Yu. M. Lopatin, D. A. Yakhontov, Panchenko Ep, I. V. Fomin, G. P. Arutunov
Publikováno v:
Kardiologiia. 61(5)
On December 18, 2020, an expert council was held with the participation of members of the Russian Society of Cardiology, the Eurasian Association of Ther-apists, the National Society for Atherothrombosis, the National Society for Evi-dence-Based Phar
Autor:
A. B. Dobrovolsky, Panchenko Ep, Kropacheva Es, V M Mironov, E N Krivosheeva, Titaeva Ev, A N Samko
Publikováno v:
Kardiologiia. 60(8)
Aim Searching for clinical, angiographic, and biochemical predictors of cardiovascular complications (CVC) and hemorrhagic complications in patients with atrial fibrillation (AF) receiving a multicomponent antithrombotic therapy (MAT) for an elective